Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y0VQ
|
||||
Former ID |
DNC013577
|
||||
Drug Name |
N,N'-(1',8'-octylene)-bis-(-)-nor-MEP
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529368] | ||
Structure |
Download2D MOL |
||||
Formula |
C36H56N2O2
|
||||
Canonical SMILES |
CCC1(CCCCN(C1)CCCCCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=<br />CC(=CC=C4)O
|
||||
InChI |
1S/C36H56N2O2/c1-3-35(31-17-15-19-33(39)27-31)21-9-13-25-37(29-35)23-11-7-5-6-8-12-24-38-26-14-10-22-36(4-2,30-38)32-18-16-20-34(40)28-32/h15-20,27-28,39-40H,3-14,21-26,29-30H2,1-2H3/t35-,36-/m1/s1
|
||||
InChIKey |
XFXBGPOUAKCCMC-LQFQNGICSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [529368] | |
Cholinesterase | Target Info | Inhibitor | [529368] | ||
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.